SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 171 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $14,798,000 | +105.6% | 824,588 | +35.3% | 0.00% | 0.0% |
| Q3 2017 | $7,196,000 | +14.4% | 609,582 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $6,290,000 | +2.3% | 599,420 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $6,148,000 | -22.0% | 558,491 | -4.0% | 0.00% | 0.0% |
| Q4 2016 | $7,882,000 | +46.1% | 581,835 | +32.9% | 0.00% | 0.0% |
| Q3 2016 | $5,395,000 | +15.0% | 437,929 | +2.4% | 0.00% | 0.0% |
| Q2 2016 | $4,692,000 | -1.4% | 427,527 | -1.9% | 0.00% | 0.0% |
| Q1 2016 | $4,760,000 | -75.5% | 435,733 | -61.2% | 0.00% | -50.0% |
| Q4 2015 | $19,420,000 | -33.7% | 1,123,163 | -23.8% | 0.00% | -33.3% |
| Q3 2015 | $29,275,000 | +475.0% | 1,473,077 | +375.7% | 0.00% | +200.0% |
| Q2 2015 | $5,091,000 | +26.7% | 309,692 | +20.1% | 0.00% | – |
| Q1 2015 | $4,018,000 | +20.5% | 257,874 | +10.4% | 0.00% | – |
| Q4 2014 | $3,334,000 | +134.0% | 233,529 | +6.5% | 0.00% | – |
| Q3 2014 | $1,425,000 | -4.7% | 219,363 | +1.1% | 0.00% | – |
| Q2 2014 | $1,495,000 | +0.4% | 216,874 | +4.1% | 0.00% | – |
| Q1 2014 | $1,489,000 | -45.9% | 208,409 | -47.7% | 0.00% | – |
| Q4 2013 | $2,753,000 | +148.9% | 398,505 | +124.0% | 0.00% | – |
| Q3 2013 | $1,106,000 | -11.7% | 177,912 | -6.5% | 0.00% | – |
| Q2 2013 | $1,252,000 | – | 190,267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
| NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
| IFP Advisors, Inc | 384 | $7,000 | 0.00% |
| GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |